Type i interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis

Journal of the Neurological Sciences

Volumn 313, Issue 1-2, 2012, Pages 48-53

  Feng, Xuan ^a   Reder, Nicholas P ^b   Yanamandala, Mounica ^a   Hill, Addie ^a   Franek, Beverly S ^a   Niewold, Timothy B ^a   Reder, Anthony T ^a   Javed, Adil ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Interferon; MS; MxA; NMO; SLE; STAT1

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; MYXOVIRUS RESISTANCE PROTEIN A; PHOSPHOSERINE; PHOSPHOTYROSINE; STAT1 PROTEIN;

ADULT; ARTICLE; BIOASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERFERON TYPE I; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROMYELITIS OPTICA; UP-REGULATION;

EID: 84855604535     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.09.032     Document Type: Article

References (43)

1. V.A. Lennon, D.M. Wingerchuk, T.J. Kryzer, S.J. Pittock, C.F. Lucchinetti, and K. Fujihara A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis Lancet 364 2004 2106 2112 (Pubitemid 39626806)
2. D.M. Wingerchuk, V.A. Lennon, S.J. Pittock, C.F. Lucchinetti, and B.G. Weinshenker Revised diagnostic criteria for neuromyelitis optica Neurology 66 2006 1485 1489 (Pubitemid 43958540)
3. S.J. Pittock, V.A. Lennon, J. de Seze, P. Vermersch, H.A. Homburger, and D.M. Wingerchuk Neuromyelitis optica and non organ-specific autoimmunity Arch Neurol 65 2008 78 83
4. B.G. Weinshenker Neuromyelitis optica: what it is and what it might be Lancet 361 2003 889 890 (Pubitemid 36332102)
5. D.M. Wingerchuk, W.F. Hogancamp, P.C. O'Brien, and B.G. Weinshenker The clinical course of neuromyelitis optica (Devic's syndrome) Neurology 53 1999 1107 1114 (Pubitemid 29442132)
6. D. Giorgi, C. Balacco Gabrieli, and L. Bonomo The association of optic neuropathy with transverse myelitis in systemic lupus erythematosus Rheumatology 38 1999 191 192 (Pubitemid 29507248)
7. A. Javed, R. Balabanov, B.G. Arnason, T.J. Kelly, N.J. Sweiss, and P. Pytel Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis Mult Scler 14 2008 809 814
8. R.C. Collard, R.P. Koehler, and D.H. Mattson Frequency and significance of antinuclear antibodies in multiple sclerosis Neurology 49 1997 857 861 (Pubitemid 27428036)
9. A. Javed, and A.T. Reder Therapeutic role of beta-interferons in multiple sclerosis Pharmacol Ther 110 2006 35 56 (Pubitemid 43248725)
10. A.T. Reder, and B.G.W. Arnason Immunology of multiple sclerosis P.J. Vinken, G.W. Bruyn, H.L. Klawans, J.C. Koetsier, Handbook of clinical neurology: demyelinating diseases 1985 Elsevier Science Publishers Amsterdam 337 395
11. E.C. Baechler, F.M. Batliwalla, G. Karypis, P.M. Gaffney, W.A. Ortmann, and K.J. Espe Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus Proc Natl Acad Sci U S A 100 2003 2610 2615 (Pubitemid 36297546)
12. K.A. Kirou, C. Lee, S. George, K. Louca, M.G. Peterson, and M.K. Crow Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease Arthritis Rheum 52 2005 1491 1503 (Pubitemid 40663941)
13. T.B. Niewold, J.A. Kelly, M.H. Flesch, L.R. Espinoza, J.B. Harley, and M.K. Crow Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients Arthritis Rheum 58 2008 2481 2487
14. J.E. Gottenberg, N. Cagnard, C. Lucchesi, F. Letourneur, S. Mistou, and T. Lazure Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome Proc Natl Acad Sci U S A 103 2006 2770 2775
15. E.S. Emamian, J.M. Leon, C.J. Lessard, M. Grandits, E.C. Baechler, and P.M. Gaffney Peripheral blood gene expression profiling in Sjögren's syndrome Genes Immun 10 2009 285 296
16. B. Bonaci-Nikolic, I. Jeremic, S. Andrejevic, M. Sefik-Bukilica, N. Stojsavljevic, and J. Drulovic Anti-double stranded DNA and lupus syndrome induced by interferon-beta therapy in a patient with multiple sclerosis Lupus 18 2009 78 80
17. V. Ho, A. McLean, and S. Terry Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C J Clin Rheumatol 14 2008 166 168
18. M. Krumbholz, H. Faber, F. Steinmeyer, L.A. Hoffmann, T. Kumpfel, and H. Pellkofer Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity Brain 131 2008 1455 1463 (Pubitemid 351806460)
19. J. Palace, M.I. Leite, A. Nairne, and A. Vincent Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers Arch Neurol 67 2010 1016 1017
20. J. Shimizu, Y. Hatanaka, M. Hasegawa, A. Iwata, I. Sugimoto, and H. Date IFN-β-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum Neurology 75 2010 1423 1427
21. M. Tanaka, K. Tanaka, and M. Komori Interferon-β (1b) treatment in neuromyelitis optica Eur Neurol 62 2009 167 170
22. A. Uzawa, M. Mori, S. Hayakawa, S. Masuda, and S. Kuwabara Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis Eur J Neurol 17 2010 672 676
23. M.K. Crow Interferon-alpha: a therapeutic target in systemic lupus erythematosus Rheum Dis Clin North Am 36 2010 173 186
24. K.P. Wandinger, K. Wessel, P. Trillenberg, N. Heindl, and H. Kirchner Effect of high-dose methylprednisolone administration on immune functions in multiple sclerosis patients Acta Neurol Scand 97 1998 359 365 (Pubitemid 28275906)
25. W.J. Jabs, C. Hennig, R. Zawatzky, and H. Kirchner Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta J Interferon Cytokine Res 19 1999 463 469 (Pubitemid 29269936)
26. X. Feng, A.L. Petraglia, M. Chen, P.V. Byskosh, M.D. Boos, and A.T. Reder Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1 J Neuroimmunol 129 2002 205 215 (Pubitemid 34874925)
27. T.B. Niewold, J. Hua, T.J. Lehman, J.B. Harley, and M.K. Crow High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus Genes Immun 8 2007 492 502 (Pubitemid 47365615)
28. R.C. Axtell, B.A. de Jong, K. Boniface, L.F. van der Voort, R. Bhat, and P. De Sarno T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis Nat Med 16 2010 406 412
29. L.F. van der Voort, A. Vennegoor, A. Visser, D.L. Knol, B.M. Uitdehaag, and F. Barkhof Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS Neurology 75 2010 1228 1233
30. M. Comabella, J.D. Lunemann, J. Rio, A. Sanchez, C. Lopez, and E. Julia A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis Brain 132 2009 3353 3365
31. A.T. Reder MxA: a biomarker for predicting multiple sclerosis disease activity Neurology 75 2010 1222 1223
32. K.D. Yamaguchi, D.L. Ruderman, E. Croze, T.C. Wagner, S. Velichko, and A.T. Reder IFN-β-regulated genes show abnormal expression in therapy-naive relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions J Neuroimmunol 195 2008 116 120
33. A.T. Reder, S. Velichko, K.D. Yamaguchi, K. Hamamcioglu, K. Ku, and J. Beekman IFN-β-1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression J Interferon Cytokine Res 28 2008 317 331 (Pubitemid 351725305)
34. J. Hua, K. Kirou, C. Lee, and M.K. Crow Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies Arthritis Rheum 54 2006 1906 1916 (Pubitemid 43877940)
35. T.B. Niewold, J. Hua, T.J. Lehman, J.B. Harley, and M.K. Crow High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus Genes Immun 8 2007 492 502 (Pubitemid 47365615)
36. T.B. Niewold, S.N. Kariuki, G.A. Morgan, S. Shrestha, and L.M. Pachman Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy Arthritis Rheum 60 2009 1815 1824
37. J. Groom, S.L. Kalled, A.H. Cutler, C. Olson, S.A. Woodcock, and P. Schneider Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome J Clin Invest 109 2002 59 68 (Pubitemid 34052542)
38. Liu Z, Davidson A. BAFF inhibition: a new class of drugs for the treatment of autoimmunity. Exp Cell Res. Epub 02-22-11.
39. A. Vaknin-Dembinsky, L. Brill, N. Orpaz, O. Abramsky, and D. Karussis Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population Mult Scler 16 2010 1453 1457
40. F. Gilli Role of differential expression of interferon receptor isoforms on the response of multiple sclerosis patients to therapy with interferon beta J Interferon Cytokine Res 30 2010 733 741
41. B. Oliver-Martos, T. Orpez, M.J. Pinto-Medel, C. Mayorga, J.A. Garcia-Leon, and R. Maldonado-Sanchez Gene expression in IFN β signalling pathway differs between monocytes, CD4 and CD8 T cells from MS patients J Neuroimmunol 230 2011 153 159
42. S.A. Dupont, S. Goelz, J. Goyal, and M. Green Mechanisms for regulation of cellular responsiveness to human IFN-beta1a J Interferon Cytokine Res 22 2002 491 501 (Pubitemid 34579552)
43. R.C. Littell, J. Pendergast, and R. Natarajan Modelling covariance structure in the analysis of repeated measures data Stat Med 19 2000 1793 1819 (Pubitemid 30436064)